Cipla Gulf FZ LCC is expanding its partnership with Alvotech for the marketing and distribution of four biosimilar medicines in Australia and New Zealand, the company said in a regulatory filing.
Original source: https://health.economictimes.indiatimes.com/news/pharma/81289040?utm_source=RSS&utm_medium=ETRSS
